Low NEDD4L expression is associated with larger tumor size, increased vascular invasion, lower differentiation, more lymph node and distant metastases, and progressive tumor stage (Sakashita et al., 2013; Yang et al., 2015; Li G. et al., 2022). Here, NEDD4L is linked to neoplasm.